Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel

BACKGROUND: This analysis compared the quality-adjusted survival and clinical outcomes of albumin-bound paclitaxel+carboplatin (nab-PC) vs solvent-based paclitaxel+carboplatin (sb-PC) as first-line therapy in advanced non-small-cell lung cancer (NSCLC) in older patients. METHODS: Using age-based sub...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Cancer
Main Authors: Langer, C J, Hirsh, V, Okamoto, I, Lin, F-J, Wan, Y, Whiting, S, Ong, T J, Renschler, M F, Botteman, M F
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2015
Teme:
Clinical Studies
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4647528/
https://ncbi.nlm.nih.gov/pubmed/26035702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.181
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki